Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung disease.

Authors: Alysandratos, Konstantinos-Dionysios; Russo, Scott J; Petcherski, Anton; Taddeo, Evan P; Acín-Pérez, Rebeca; Villacorta-Martin, Carlos; Jean, J C; Mulugeta, Surafel; Rodriguez, Luis R; Blum, Benjamin C; Hekman, Ryan M; Hix, Olivia T; Minakin, Kasey; Vedaie, Marall; Kook, Seunghyi; Tilston-Lunel, Andrew M; Varelas, Xaralabos; Wambach, Jennifer A; Cole, F Sessions; Hamvas, Aaron; Young, Lisa R; Liesa, Marc; Emili, Andrew; Guttentag, Susan H; Shirihai, Orian S; Beers, Michael F; Kotton, Darrell N

Published In Cell Rep, (2021 Aug 31)

Abstract: Alveolar epithelial type 2 cell (AEC2) dysfunction is implicated in the pathogenesis of adult and pediatric interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF); however, identification of disease-initiating mechanisms has been impeded by inability to access primary AEC2s early on. Here, we present a human in vitro model permitting investigation of epithelial-intrinsic events culminating in AEC2 dysfunction, using patient-specific induced pluripotent stem cells (iPSCs) carrying an AEC2-exclusive disease-associated variant (SFTPCI73T). Comparing syngeneic mutant versus gene-corrected iPSCs after differentiation into AEC2s (iAEC2s), we find that mutant iAEC2s accumulate large amounts of misprocessed and mistrafficked pro-SFTPC protein, similar to in vivo changes, resulting in diminished AEC2 progenitor capacity, perturbed proteostasis, altered bioenergetic programs, time-dependent metabolic reprogramming, and nuclear factor κB (NF-κB) pathway activation. Treatment of SFTPCI73T-expressing iAEC2s with hydroxychloroquine, a medication used in pediatric ILD, aggravates the observed perturbations. Thus, iAEC2s provide a patient-specific preclinical platform for modeling the epithelial-intrinsic dysfunction at ILD inception.

PubMed ID: 34469722 Exiting the NIEHS site

MeSH Terms: No MeSH terms associated with this publication

Back
to Top